Primary effusion lymphoma: current perspectives

References

• JarrettRFViruses and lymphoma/leukaemiaJ Pathol2006208217618616362996
   PubMed Web of Science ®Google Scholar
• ChangYCesarmanEPessinMSIdentification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcomaScience19942665192186518697997879
   PubMed Web of Science ®Google Scholar
• CesarmanEChangYMoorePSSaidJWKnowlesDMKaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomasN Engl J Med199533218118611917700311
   PubMed Web of Science ®Google Scholar
• KaplanLDHuman herpesvirus-8: Kaposi sarcoma, multicentric Castle-man disease, and primary effusion lymphomaHematol Am Soc Hematol Educ Program20132013103108
   PubMed Web of Science ®Google Scholar
• CastilloJJShumHLahijaniMWinerESButeraJNPrognosis in primary effusion lymphoma is associated with the number of body cavities involvedLeuk Lymphoma201253122378238222591071
   PubMed Web of Science ®Google Scholar
• ChenY-BRahemtullahAHochbergEPrimary effusion lymphomaOncologist200712556957617522245
   PubMed Web of Science ®Google Scholar
• BoulangerEHermineOFermandJ-PHuman herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patientsAm J Hematol2004761889115114607
   PubMed Web of Science ®Google Scholar
• BoulangerEAfonsoPVYahiaouiYAdle-BiassetteHGabarreJAgbalikaFHuman herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycinAm J Transplant20088370771018261181
   PubMed Web of Science ®Google Scholar
• SaidJWTasakaTTakeuchiSPrimary effusion lymphoma in women: report of two cases of Kaposi’s sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative womenBlood1996888312431288874212
   PubMed Web of Science ®Google Scholar
• SasakiYIsegawaTShimabukuroAYonahaTYonahaHPrimary effusion lymphoma in an elderly HIV-negative patient with hemodialysis: importance of evaluation for pleural effusion in patients receiving hemodialysisCase Rep Nephrol Urol2014429510224987405
   PubMedGoogle Scholar
• DunleavyKWilsonWHHow I treat HIV-associated lymphomaBlood2012119143245325522337719
   PubMed Web of Science ®Google Scholar
• SwerdlowSHCampoEHarrisNLWHO Classification of Tumours of Haematopoietic and Lymphoid TissuesRevised 4th ed2LyonInternational Agency for Research on Cancer2016
   Google Scholar
• CarboneAGloghiniAKSHV/HHV8-associated lymphomasBr J Haematol20081401132417991301
   PubMed Web of Science ®Google Scholar
• SaidJKaposi’s sarcoma-associated herpesvirus (KSHV): a new viral pathogen associated with Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s diseaseWest J Med1997167137389265864
   PubMedGoogle Scholar
• FriborgJJrKongWHottigerMONabelGJp53 inhibition by the LANA protein of KSHV protects against cell deathNature1999402676488989410622254
   PubMed Web of Science ®Google Scholar
• RadkovSAKellamPBoshoffCThe latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cellsNat Med20006101121112711017143
   PubMed Web of Science ®Google Scholar
• DeCotiisJLLukacDMKSHV and the role of NOTCH receptor dysregulation in disease progressionPathogens201763E34
   Web of Science ®Google Scholar
• DirekzeSLamanHRegulation of growth signalling and cell cycle by Kaposi’s sarcoma-associated herpesvirus genesInt J Exp Pathol200485630531915566428
   PubMed Web of Science ®Google Scholar
• SakakibaraSTosatoGViral interleukin-6: role in Kaposi’s sarcoma-associated herpesvirus–associated malignanciesJ Interferon Cytokine Res2011311179180121767154
   PubMed Web of Science ®Google Scholar
• ElySAPowersJLewisDKaposi’s sarcoma-associated herpesvirus-positive primary effusion lymphoma arising in the suba-rachnoid spaceHum Pathol199930898198410452513
   PubMed Web of Science ®Google Scholar
• PielasinskiUSantonjaCRodríguez-PinillaSMRequenaLExtracavitary primary effusion lymphoma presenting as a cutaneous tumor: a case report and literature reviewJ Cutan Pathol201441974575324917369
   PubMed Web of Science ®Google Scholar
• InoueSMiyamotoTYoshinoTYamadoriIHagariYYamamotoOPrimary effusion lymphoma with skin involvementJ Clin Pathol200659111221122217071811
   PubMed Web of Science ®Google Scholar
• IbrahimUSaqibAMohammadFDingJHusseinSAtallahJPKSHV-associated extracavitary primary effusion lymphoma in an HIV seronegative patient: a case report and review of the literaturePostgrad Med2017129340240728122468
   PubMed Web of Science ®Google Scholar
• Kabiawu-AjiseOEHarrisJIsmailiNAmorosiEIbrahimSPrimary effusion lymphoma with central nervous system involvement in an HIV-negative homosexual maleActa Haematol20121282778222699313
   PubMed Web of Science ®Google Scholar
• ChadburnAHyjekEMathewSCesarmanESaidJKnowlesDMKSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphomaAm J Surg Pathol200428111401141615489644
   PubMed Web of Science ®Google Scholar
• MedeirosBCManessLJBauerFARossJWKapurDUnusual presentation of “extracavitary” primary effusion lymphoma in previously unknown HIV diseaseConn Med2000641059159411100630
   PubMedGoogle Scholar
• PantanowitzLWuZDezubeBJPihanGExtracavitary primary effusion lymphoma of the anorectumClin Lymphoma Myeloma20056214915216231856
   PubMedGoogle Scholar
• KimYLeventakiVBhaijeeFJacksonCCMedeirosLJVegaFExtracavitary/solid variant of primary effusion lymphomaAnn Diagn Pathol201216644144622497739
   PubMed Web of Science ®Google Scholar
• SantonjaCMedina-PuenteCSerrano Del CastilloCCabello ÚbedaARodríguez-PinillaSMPrimary effusion lymphoma involving cerebrospinal fluid, deep cervical lymph nodes and adenoids. Report of a case supporting the lymphatic connection between brain and lymph nodesNeuropathology201737324925827862361
   PubMed Web of Science ®Google Scholar
• NadorRGCesarmanEChadburnAPrimary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virusBlood19968826456568695812
   PubMed Web of Science ®Google Scholar
• BrimoFMichelRPKhetaniKAugerMPrimary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosisCancer2007111422423317554754
   PubMed Web of Science ®Google Scholar
• KleinUGloghiniAGaidanoGGene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcriptsBlood2003101104115412112531789
   PubMed Web of Science ®Google Scholar
• GaidanoGCapelloDCiliaAMGenetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesisGenes Chromosomes Cancer199924116239892104
   PubMed Web of Science ®Google Scholar
• YangDChenWXiongJSherrodCJHenryDHDittmerDPInterleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphomaProc Natl Acad Sci U S A201411144E4762E476825341731
   PubMed Web of Science ®Google Scholar
• ChesonBDFisherRIBarringtonSFRecommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classificationJ Clin Oncol201432273059306825113753
   PubMed Web of Science ®Google Scholar
• BoulangerEGérardLGabarreJPrognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDSJ Clin Oncol200523194372438015994147
   PubMed Web of Science ®Google Scholar
• LittleRFPittalugaSGrantNHighly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biologyBlood2003101124653465912609827
   PubMed Web of Science ®Google Scholar
• El-AyassWYuE-MKarcherDSAragon-ChingJBComplete response to EPOCH in a patient with HIV and extracavitary primary effusion lymphoma involving the colon: a case report and review of literatureClin Lymphoma Myeloma Leuk201212214414722264773
   PubMed Web of Science ®Google Scholar
• SimonelliCSpinaMCinelliRClinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution studyJ Clin Oncol200321213948395414581418
   PubMed Web of Science ®Google Scholar
• BoulangerEDanielM-TAgbalikaFOksenhendlerECombined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphomaAm J Hematol200373314314812827649
   PubMed Web of Science ®Google Scholar
• TerasakiYOkumuraHSaitoKHHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximabIntern Med200847242175217819075546
   PubMed Web of Science ®Google Scholar
• SuzukiKInoKSugawaraYMizutaniMSekineTKatayamaNProlonged survival in a patient with human herpesvirus-8-negative primary effusion lymphoma after combination chemotherapy with rituximabGan To Kagaku Ryoho2008354691694 In Japanese18408447
   PubMedGoogle Scholar
• FosterWRBischinADorerRAboulafiaDMHuman herpesvirus type 8-associated large B-cell lymphoma: a nonserous extracavitary variant of primary effusion lymphoma in an HIV-infected man: a case report and review of the literatureClin Lymphoma Myeloma Leuk201616631132127234438
   PubMed Web of Science ®Google Scholar
• OksenhendlerEClauvelJPJouveshommeSDaviFMansourGComplete remission of a primary effusion lymphoma with antiretroviral therapyAm J Hematol1998573266
   PubMed Web of Science ®Google Scholar
• WilliamsonSJNicolSMStürzlMSabbahSHislopADAzidothymidine sensitizes primary effusion lymphoma cells to Kaposi sarcoma-associated herpesvirus-specific CD4+ T cell control and inhibits vIRF3 functionPLoS Pathog20161211e100604227893813
   PubMed Web of Science ®Google Scholar
• KariyaRTauraMSuzuSKaiHKatanoHOkadaSHIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathwayCancer Lett20143421525924012878
   PubMed Web of Science ®Google Scholar
• WaddingtonTWAboulafiaDMFailure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature reviewAIDS Patient Care STDs2004182677315006181
   PubMed Web of Science ®Google Scholar
• WonJ-HHanS-HBaeS-BSuccessful eradication of relapsed primary effusion lymphoma with high-dose chemotherapy and autologous stem cell transplantation in a patient seronegative for human immunodeficiency virusInt J Hematol200683432833016757433
   PubMed Web of Science ®Google Scholar
• BryantAMillikenSSuccessful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphomaBiol Blood Marrow Transplant200814560160218410904
   PubMed Web of Science ®Google Scholar
• KlassCMOffermannMKTargeting human herpesvirus-8 for treatment of Kaposi’s sarcoma and primary effusion lymphomaCurr Opin Oncol200517544745516093794
   PubMed Web of Science ®Google Scholar
• KedesDHGanemDSensitivity of Kaposi’s sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapyJ Clin Invest1997999208220869151779
   PubMed Web of Science ®Google Scholar
• MarquetJVelazquez-KennedyKLópezSBenitoABlanchardM-JGarcia-VelaJACase report of a primary effusion lymphoma successfully treated with oral valganciclovir after failing chemotherapyHematol Oncol201836131631928580733
   PubMed Web of Science ®Google Scholar
• HocquelouxLAgbalikaFOksenhendlerEMolinaJMLong-term remission of an AIDS-related primary effusion lymphoma with antiviral therapyAIDS200115228028211216942
   PubMed Web of Science ®Google Scholar
• HalfdanarsonTRMarkovicSNKalokheULuppiMA non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapyAnn Oncol200617121849185016766593
   PubMed Web of Science ®Google Scholar
• LuppiMTrovatoRBarozziPTreatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovirLeukemia200519347347615674353
   PubMed Web of Science ®Google Scholar
• NasreenNMohammedKADowlingPAWardMJGalffyGAntonyVBTalc induces apoptosis in human malignant mesothelioma cells in vitroAm J Respir Crit Care Med20001612 Pt 159560010673205
   PubMed Web of Science ®Google Scholar
• BirsenRBoutboulDCrestaniBTalc pleurodesis allows long-term remission in HIV-unrelated Human Herpesvirus 8-associated primary effusion lymphomaLeuk Lymphoma20175881993199828084853
   PubMed Web of Science ®Google Scholar
• RaedlerLVelcade (Bortezomib) receives 2 new FDA indications: for retreatment of patients with multiple myeloma and for first-line treatment of patients with mantle-cell lymphomaAm Health Drug Benefits20158Spec Feature13514026629279
   PubMedGoogle Scholar
• SiddiqiTJoyceRMA case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximabClin Lymphoma Myeloma20088530030418854285
   PubMedGoogle Scholar
• BhattSAshlockBMToomeyNLEfficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphomaJ Clin Invest201312362616262823635777
   PubMed Web of Science ®Google Scholar
• ADCETRIS^® (brentuximab vedotin) | U.S. | Seattle Genetics http://www.seattlegenetics.com/products/adcetris-usAccessed February 24, 2018
   Google Scholar
• BhattSAshlockBMNatkunamYCD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphomaBlood201312271233124223838350
   PubMed Web of Science ®Google Scholar
• JacobsenEDSharmanJPOkiYBrentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expressionBlood201512591394140225573987
   PubMed Web of Science ®Google Scholar
• SinS-HRoyDWangLRapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signalingBlood200710952165217317082322
   PubMed Web of Science ®Google Scholar
• AokiYTosatoGRole of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi’s sarcoma-associated herpesvirus-infected primary effusion lymphomasBlood199994124247425410590069
   PubMed Web of Science ®Google Scholar
• GotoHKudoEKariyaRTauraMKatanoHOkadaSTargeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphomaJ Cancer Res Clin Oncol2015141346547425304617
   PubMed Web of Science ®Google Scholar
• DimopoulosMAKastritisERajkumarSVTreatment of plasma cell dyscrasias with lenalidomideLeukemia20082271343135318509355
   PubMed Web of Science ®Google Scholar
• Trisenox (Arsenic trioxide) [package insert]Teva Pharmaceuticals USA, IncNorth Wales, PA 19454
   Google Scholar
• HleihelRTawilNKaramMMerhiRABazarbachiAHajjHEArsenic trioxide and lenalidomide: a promising combination therapy for primary effusion lymphomaBlood2017130Suppl 12817
   Google Scholar
• CassoniAAliUCaveJRemission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphomaJ Clin Oncol200826325297529918854561
   PubMed Web of Science ®Google Scholar